Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Nanoform appoints new head of investor relations
Nanoform appoints new head of investor relations
Henri von Haartman will be the company’s new Director of Investor Relations
Verona Pharma makes two senior appointments
Verona Pharma makes two senior appointments
Nina Church joins as Executive Director of Global Clinical Development and Nancy Herje as Senior Director of Clinical Operations
Mereo BioPharma appoints Head of Pharmaceutical Development
Mereo BioPharma appoints Head of Pharmaceutical Development
Cambrex makes three senior appointments
Cambrex makes three senior appointments
Bruno Biscaro has been appointed President of Drug Products, Joe Nettleton as President of Drug Substance, and Simon Edwards as President of CDMO Sales & Marketing
The Marchesini Group appoints new Sales Director
The Marchesini Group appoints new Sales Director
Francesco Stanzani will start his new role with immediate effect based in Pianoro
Medherant appoints new CEO
Medherant appoints new CEO
John Burt will replace Current CEO, Nigel Davis, who will stay on as Chief Business Officer
Connect 2 Cleanrooms appoints new MD and CEO
Connect 2 Cleanrooms appoints new MD and CEO
Michael Wright will succeed founding MD Joe Govier who has moved to the CEO role
Ex-FDA Commissioner joins Pfizer
Ex-FDA Commissioner joins Pfizer
Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board
Newcomer Quell Therapeutics appoints Iain McGill as CEO
Newcomer Quell Therapeutics appoints Iain McGill as CEO
The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School
Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics
Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics
In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform
Domain Therapeutics adds Sylvie Ryckebusch to Board
Domain Therapeutics adds Sylvie Ryckebusch to Board
Ryckebusch joins Domain from Merck Serono
Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach
Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach
Caddy-Leach will take on the role of Business Development Manager to support growing US presence
MG America appoints Janice Wortham as Regional Sales Manager
MG America appoints Janice Wortham as Regional Sales Manager
Wortham will cover the Processing division covering some on the most important pharma stronghold in the US
ReViral appoints Alex Sapir as new CEO
ReViral appoints Alex Sapir as new CEO
Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington
Uhlmann Packaging Systems has new US Regional Sales Manager
Uhlmann Packaging Systems has new US Regional Sales Manager
Markus Leuprecht will take over leading the Southwestern US and Texas
Lyndra Therapeutics has new CEO
Lyndra Therapeutics has new CEO
Dr Patricia Hurter will begin her new post on 3 September
TraceLink appoints four new Board Members
TraceLink appoints four new Board Members
New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins
Ulrich Platte is new CFO of eTheRNA immunotherapies
Ulrich Platte is new CFO of eTheRNA immunotherapies
Platte will start at the mRNA immunotherapy company on 3 June
Idifarma announces new Director of Operations
Idifarma announces new Director of Operations
Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals
Buhler Group adds former Rehau Group CEO to Board
Buhler Group adds former Rehau Group CEO to Board
Rainer Schulz will be a new member of the Board of Directors
Immodulon appoints new CSO
Immodulon appoints new CSO
Effective immediately Thomas Kleen will take on the role within the senior management team
Dr William F Feehery is new Certara CEO
Dr William F Feehery is new Certara CEO
Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company
Prudential family leadership goes to third generation
Prudential family leadership goes to third generation
John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position
Asceneuron appoints new Board Member
Asceneuron appoints new Board Member
Dr Eric Yuen will join the company and help initiate later stage clinical development in the tau pathology space
Previous
1
…
19
20
21
22
(current)
23
24
25
…
140
Next
Trending Articles
Upcoming event
Enhancing probiotic stability through smarter formulation and packaging strategies
18 September 2025 | Virtual
See all